INVERNIZZI PIETRO

Ciardullo, S., Muraca, E., Vergani, M., Invernizzi, P., Perseghin, G. (2024). Advancements in pharmacological treatment of NAFLD/MASLD: a focus on metabolic and liver-targeted interventions. GASTROENTEROLOGY REPORT, 12, 1-10 [10.1093/gastro/goae029]. Detail

Corpechot, C., Lemoinne, S., Soret, P., Hansen, B., Hirschfield, G., Gulamhusein, A., et al. (2024). Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain?. HEPATOLOGY, 79(1), 39-48 [10.1097/HEP.0000000000000529]. Detail

Massironi, S., Franchina, M., Ippolito, D., Elisei, F., Falco, O., Maino, C., et al. (2024). Improvements and future perspective in diagnostic tools for neuroendocrine neoplasms. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 19(4), 349-366 [10.1080/17446651.2024.2363537]. Detail

Riva, M., Valnegri, C., Invernizzi, P. (2024). The liver in Christian thought: Symbolism, morality, and spirituality. CLINICAL LIVER DISEASE, 23(1) [10.1097/cld.0000000000000236]. Detail

Gerussi, A., Cappadona, C., Bernasconi, D., Cristoferi, L., Valsecchi, M., Carbone, M., et al. (2024). Improving predictive accuracy in primary biliary cholangitis: A new genetic risk score. LIVER INTERNATIONAL, 44(8 (August 2024)), 1952-1960 [10.1111/liv.15916]. Detail